Phase 3 Trials

Efficacy Studies Drug Efficacy Patient Studies Vaccine Efficacy Cancer Vaccines ELAINE-3 Trial ACHIEVE-1 Trial Vaccine Efficacy Trials Drug Testing REGAL Trial ACHIEVE-1 Trials EAGLE-1 Trial Patient Participation Lipfendra Trials RASolute 302 Melanoma Pelabresib Trial Tuberculosis Vaccine Trials Rybelsus ATTAIN-1 Trial OASIS 4 Vaccine Trials Participant Demographics SOUL Trial WU-KONG28 Trial Weight Loss Efficacy Eosinophilic Asthma Psilocybin Trials Results Reporting AFFINE Trial Weight Loss Maintenance Metabolic Dysfunction Interim Analysis GanLum Trial

9 ARTICLES

last wk.

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

The decision opens the first effective targeted option against KRAS-driven pancreatic tumors, raising urgent questions about pricing, payer access, and the drug’s commercial rollout.

21 ARTICLES

last wk.

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

5 ARTICLES

last mo.

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

5 ARTICLES

6mo ago

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

4 ARTICLES

8mo ago

FDA Grants Priority Review to Vera's Atacicept for IgA Nephropathy

3 ARTICLES

8mo ago

Athira Pharma Secures Exclusive Lasofoxifene Rights, Raises $90 Million to Advance Phase 3 Breast Cancer Program

4 ARTICLES

8mo ago

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

15 ARTICLES

8mo ago

FDA Approves Two First-in-Class Oral Treatments for Gonorrhea

4 ARTICLES

9mo ago

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

9 ARTICLES

9mo ago

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

6 ARTICLES

10mo ago

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

5 ARTICLES

11mo ago

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug

5 ARTICLES

11mo ago

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

5 ARTICLES

last yr.

FDA Approves First New Fibromyalgia Treatment in 15 Years

8 ARTICLES

last yr.

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

4 ARTICLES

last yr.

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

10 ARTICLES

last yr.

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

Phase 3 Trials

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

FDA Grants Priority Review to Vera's Atacicept for IgA Nephropathy

Athira Pharma Secures Exclusive Lasofoxifene Rights, Raises $90 Million to Advance Phase 3 Breast Cancer Program

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

FDA Approves Two First-in-Class Oral Treatments for Gonorrhea

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Never miss stories about

Phase 3 Trials

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

FDA Approves First New Fibromyalgia Treatment in 15 Years

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

Never miss stories about

Phase 3 Trials